$APGE appeared in 7 mentions across 3 distinct FinTwit voices over a 12-month period, with the first mention on 2026-01-06 and the most recent on 2026-06-22. Biotech-focused voices dominated discussion of the stock. @adamfeuerstein led engagement with 5 mentions, followed by @alphaticaio and @investmentguru_ with 1 mention each. The ticker gained significant attention in mid-to-late June 2026 following acquisition news, with @alphaticaio reporting on 2026-06-19 that AbbVie was nearing a $10.9 billion deal to acquire Apogee Therapeutics.

On 2026-06-22, the acquisition was confirmed as completed, with @adamfeuerstein posting that AbbVie had completed the $10.9 billion purchase. The same day, @investmentguru_ noted $APGE among notable pre-market movers, showing a 54% gain alongside other biotech and small-cap stocks experiencing significant pre-market volatility driven by news catalysts and float dynamics.